temozolomide has been researched along with silicon in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, J; Wu, X; Xie, Y; Yang, X; Zeng, X; Zhu, Y | 1 |
| Bai, X; Hu, M; Jia, L; Li, Y; Tan, X; Wang, Q; Yang, X; Zeng, X; Zhang, Z; Zhu, Y | 1 |
| Chowdhury, T; Kang, RH; Kim, D; Kim, J; Kim, M; Lee, JY; Lee, S; Oh, JH; Park, CK; Park, J; Shin, J | 1 |
3 other study(ies) available for temozolomide and silicon
| Article | Year |
|---|---|
Hyperbaric oxygen as an adjuvant to temozolomide nanoparticle inhibits glioma growth by inducing G2/M phase arrest.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; G2 Phase Cell Cycle Checkpoints; Glioma; Humans; Hyperbaric Oxygenation; Mice; Nanoparticles; Oxygen; Radiation-Sensitizing Agents; Silicon; Temozolomide; Xenograft Model Antitumor Assays | 2018 |
Mild thermotherapy and hyperbaric oxygen enhance sensitivity of TMZ/PSi nanoparticles via decreasing the stemness in glioma.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Glioma; Humans; Hyperbaric Oxygenation; Hyperthermia, Induced; Mice, Nude; Nanoparticles; Neoplasm Transplantation; Neoplastic Stem Cells; Particle Size; Porosity; Rats; Silicon; Temozolomide | 2019 |
A Deep Dive: SIWV Tetra-Peptide Enhancing the Penetration of Nanotherapeutics into the Glioblastoma.
Topics: Animals; Cell Line, Tumor; Glioblastoma; Humans; Mice; Peptides; Polyethylene Glycols; Silicon; Sugars; Temozolomide | 2022 |